38
Participants
Start Date
May 20, 2011
Primary Completion Date
September 17, 2011
Study Completion Date
September 17, 2011
Firategrast immediate release tablet
Firategrast immediate release tablet is white to pale cream colored 300 mg unit dose and subjects will administer it with 240 milliliter (mL) of water.
Firategrast modified release tablet
Firategrast modified release tablet is white to slightly colored 600 mg unit dose and subjects will administer it with 240 mL of water.
Firategrast gastro-retentive solution
Firategrast solution is clear colorless solution and subject will administer it via nasogastric route.
GSK Investigational Site, Randwick
Lead Sponsor
GlaxoSmithKline
INDUSTRY